Publications by authors named "Mark K Doherty"

Claim this Profile
R
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer.
Mark K Doherty, Vincent C Tam, Mairéad G McNamara, Raymond Jang, David Hedley

Br J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab alone or with chemotherapy for metastatic non-small-cell lung cancer: A systematic review and network meta-analysis.
Suji Udayakumar, Ambica Parmar, Natasha B Leighl, Louis Everest, Vanessa S Arciero, Mark K Doherty

Crit Rev Oncol Hematol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The financial impact of cancer care on renal cancer patients.
Doreen A Ezeife, Brendon Josh Morganstein, Steven Yip, Malcolm Ryan, Jennifer H Law, Mark K Doherty

Can J Urol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care System.
Doreen A Ezeife, Brandon Josh Morganstein, Sally Lau, Jennifer H Law, Lisa W Le, Mark K Doherty

Clin Lung Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Brain Metastases and Associated Neurocognitive Aspects on Health Utility Scores in EGFR Mutated and ALK Rearranged NSCLC: A Real World Evidence Analysis.
Grainne M O'Kane, Jie Su, Brandon C Tse, Vivian Tam, Tiffany Tse, Mark K Doherty

Oncologist· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of thyroid transcription factor-1 expression is associated with poor survival in patients with advanced pulmonary adenocarcinoma treated with pemetrexed-based chemotherapy.
Mark K Doherty, Emer O'Connor, David Hannon, Aine O'Reilly, Daphne Yen

Ir J Med Sci· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and evaluation of screening dysphagia tools for observational studies and routine care in cancer patients.
Michael Borean, Kishan Shani, M Catherine Brown, Judy Chen, Mindy Liang, Mark K Doherty

Health Sci Rep· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC).
Catherine Labbé, Michael Cabanero, Grzegorz J Korpanty, Pascale Tomasini, Mark K Doherty

Lung Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer.
Mark K Doherty, Grzegorz J Korpanty, Pascale Tomasini, Moein Alizadeh, Kevin Jao

Radiother Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term responders to palliative chemotherapy for advanced biliary tract cancer.
Mark K Doherty, Mairéad G McNamara, Priya Aneja, Emma McInerney, Stephanie Moignard

J Gastrointest Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung Cancer.
Grainne M O'Kane, Catherine Labbé, Mark K Doherty, Kelvin Young, Hamzeh Albaba

Oncologist· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapy for resected biliary tract cancer: a review.
Mark K Doherty, Jennifer J Knox

Chin Clin Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central Nervous System Pseudoprogression in a Patient Treated with PD-1 Checkpoint Inhibitor.
Mark K Doherty, Kevin Jao, Frances A Shepherd, Lili-Naz Hazrati, Natasha B Leighl

J Thorac Oncol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy.
Mark K Doherty, Patrick G Morris

Int J Womens Health· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis